旭輝控股集團(00884.HK)擬先舊後新配售3.05億股、淨籌6.23億港元 午後復牌
格隆匯8月31日丨旭輝控股集團(00884.HK)宣佈,於2022年8月31日,公司、公司主要股東茂福投資(“賣方”)及配售代理訂立配售及認購協議,賣方擬透過配售代理按每股2.06港元配售約3.05億股現有股份,及賣方將以等同配售價認購約3.05億股新股份。
配售股份相當於公司現有已發行股份總數約3.33%。預期認購事項所得款項淨額約6.23億港元,公司擬用於現有債務再融資及用作一般企業用途。
此外,公司股份自8月31日下午1時起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.